BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
Portfolio Pulse from
BioAge Labs has entered a multi-year collaboration with Novartis to discover new drug targets for age-related diseases. The partnership will combine BioAge's human longevity data with Novartis' expertise in exercise biology.
December 18, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Novartis has partnered with BioAge Labs to discover novel drug targets for age-related diseases, leveraging BioAge's data and Novartis' expertise in exercise biology.
The collaboration with BioAge Labs could lead to the discovery of new drug targets, potentially enhancing Novartis' product pipeline and market position in age-related therapies. This partnership aligns with Novartis' strategic focus on innovative healthcare solutions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80